Brief: Hungary's Richter receives European Commission approval for Fylrevy
27/03/2026 09:09
March 27 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says: IT RECEIVES EUROPEAN COMMISSION APPROVAL FOR THE MARKETING AUTHORIZATION OF FYLREVY (ESTETROL TABLET, DEVELOPED UNDER THE NAME DONESTA) IT RECEIVES APPROVAL FOR FYLREVY AS HORMONE REPLACEMENT THREAPY FOR OESTROGEN DEFICIENCY SYMPTOMS IN POSTMENOPAUSAL WOMEN DECISION IS APPLICABLE FOR ALL MEMBER STATES OF THE EUROPEAN ECONOMIC AREA Source text: [https://www.bse.hu/newkibdata/129423361/Fylrevy_EC%20approval_Mar2026_EN.pdf] Further company coverage: GDRB.BU (Reporting by Anita Komuves) ((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection